These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9587520)

  • 1. [Hemorrhagic ascites disclosing massive Fasciola hepatica infection].
    Montembault S; Serfaty L; Poirot JL; Wendum D; Penna C; Poupon R
    Gastroenterol Clin Biol; 1997; 21(10):785-8. PubMed ID: 9587520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Praziquantel and Fasciola hepatica infection.
    Ripert CL
    Trans R Soc Trop Med Hyg; 1990; 84(4):610. PubMed ID: 2091367
    [No Abstract]   [Full Text] [Related]  

  • 3. [Efficacy and tolerance of praziquantel (Biltricide) in the treatment of distomatosis caused by Fasciola hepatica].
    Moreau JA; Fernandez J; Recco P; Seguela JP; Frexinos J
    Gastroenterol Clin Biol; 1995 May; 19(5):514-9. PubMed ID: 7590004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pseudotumor form of hepatic distomatosis: successful treatment with praziquantel].
    Queneau PE; Koch S; Bresson-Hadni S; Bartholomot B; Arbez-Gindre F; Heyd B; Miguet JP
    Gastroenterol Clin Biol; 1997; 21(6-7):511-3. PubMed ID: 9295980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human fascioliasis in Egyptian children: successful treatment with triclabendazole.
    el-Karaksy H; Hassanein B; Okasha S; Behairy B; Gadallah I
    J Trop Pediatr; 1999 Jun; 45(3):135-8. PubMed ID: 10401189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection with Fasciola hepatica.
    Aksoy DY; Kerimoglu U; Oto A; Erguven S; Arslan S; Unal S; Batman F; Bayraktar Y
    Clin Microbiol Infect; 2005 Nov; 11(11):859-61. PubMed ID: 16216098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A praziquantel-ineffective fascioliasis case successfully treated with triclabendazole.
    Ishii Y; Nakamura-Uchiyama F; Nawa Y
    Parasitol Int; 2002 Jun; 51(2):205-9. PubMed ID: 12113760
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Park HJ; Choi GS; Jung M; Lee SU
    Korean J Gastroenterol; 2021 Jan; 77(1):39-44. PubMed ID: 33495431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human fascioliasis.
    Saba R; Korkmaz M; Inan D; Mamikoğlu L; Turhan O; Günseren F; Cevikol C; Kabaalioğlu A
    Clin Microbiol Infect; 2004 May; 10(5):385-7. PubMed ID: 15113313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imported Fasciola hepatica infection in the United States and treatment with triclabendazole.
    Graham CS; Brodie SB; Weller PF
    Clin Infect Dis; 2001 Jul; 33(1):1-5. PubMed ID: 11389487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical presentation and management of Fasciola hepatica infection: single-center experience.
    Kaya M; Beştaş R; Cetin S
    World J Gastroenterol; 2011 Nov; 17(44):4899-904. PubMed ID: 22171131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent eosinophilic panniculitis associated with Fasciola hepatica infection.
    Perez C; Vives R; Montes M; Ostiz S
    J Am Acad Dermatol; 2000 May; 42(5 Pt 2):900-2. PubMed ID: 10767701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic vasculitis associated with Fasciola hepatica infection.
    Llanos C; Soto L; Sabugo F; Gallegos I; Valenzuela O; Verdaguer J; Cuchacovich M
    Scand J Rheumatol; 2006; 35(2):143-6. PubMed ID: 16641050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compartive studies on the effect of bithionol, praziqantel and triclabendazole in rabbit's fascioliasis. 1. Parasitological studies.
    el-Sayad MH
    J Egypt Soc Parasitol; 1997 Apr; 27(1):131-42. PubMed ID: 9097534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human fascioliasis successfully treated with triclabendazole.
    Laird PP; Boray JC
    Aust N Z J Med; 1992 Feb; 22(1):45-7. PubMed ID: 1580862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative studies on the effect of bithionol, praziquantel and triclabendazole in rabbit's fascioliasis.
    el-Bahy MM
    J Egypt Soc Parasitol; 1997 Aug; 27(2):615-6. PubMed ID: 9258000
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fasciola hepatica infection. Successful therapy using triclabendazole].
    Markwalder K; Koller M; Goebel N; Wolff K
    Schweiz Med Wochenschr; 1988 Jul; 118(27-28):1048-52. PubMed ID: 3413464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fascioliasis imported to Norway.
    Jensenius M; Flaegstad T; Stenstad T; Gjølberg T; Vlatkovic L; Schjøth-Iversen L; Berild D; Bordmann G; Myrvang B
    Scand J Infect Dis; 2005; 37(6-7):534-7. PubMed ID: 16012024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of fascioliasis in the intrahepatic duct with concurrent clonochiasis].
    Kim SH; Jung CK; Her J; Hur KH; Choi JH; Kang KH; Hwang CH
    Korean J Gastroenterol; 2014 Nov; 64(5):298-301. PubMed ID: 25420741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative studies on the effect of Bithionol, Praziquantel and Triclabendazole in rabbit's fascioliasis.
    el Sayad MH
    J Egypt Soc Parasitol; 1997 Dec; 27(3):925-6. PubMed ID: 9425836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.